Skip to main content
. 2021 Feb 19;16(2):e0247122. doi: 10.1371/journal.pone.0247122

Fig 2.

Fig 2

Kaplan-Meier curves for discharge home among survivors in the full sample crude analysis (N = 11,572) (A), in the full sample analysis with inverse probability weighting (N = 11,572) (B) and in the matched analytic sample using a 1:4 ratio (N = 130) (C) of patients who had been hospitalized for COVID-19, according to haloperidol use. The shaded areas represent pointwise 95% confidence intervals.